• Return to Headlines

Cerus Corp: The Winning Streak Continues (CERS)

By Nick Russo

Cerus Corp (NASDAQ:CERS) traded at a new 52-week high today of $7.93. This new high was reached on below average trading volume as 508,000 shares traded hands, while the average 30-day volume is approximately 987,000 shares.

Over the past year, Cerus Corp has traded in a range of $2.10 to $7.93 and is now at $7.79, 271% above that low. The 200-day and 50-day moving averages have moved 1.93% higher and 2.27% higher over the past week, respectively.

Cerus Corporation develops systems designed to enhance the safety of blood transfusions. The Company's systems inactivate pathogens in blood components and inactivate white blood cells, which are responsible for a variety of adverse transfusion reactions. Cerus' platform technologies prevent viral, bacterial, and cellular replication.

Based on a current price of $7.79, Cerus Corp is currently 10.1% above its average consensus analyst price target of $7.00. The stock should discover initial support at its 50-day moving average (MA) of $6.81 and subsequent support at its 200-day MA of $4.87.

SmarTrend is tracking the current trend status for Cerus Corp and will alert subscribers who have CERS in their portfolio or watchlist when shares have changed trend direction.

Keywords: 52 week high/lows cerus corp

Ticker(s): CERS